entertainment -WSS

entertainment

author：hotspot 2025-09-28 21:07:04 - browse：674

Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

WSS

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Patients, doctors are clashing about side effects of hormonal birth control

The United States is paying nearly triple for new Covid vaccines

FDA approves first new drug developed for postpartum depression

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Biogen nominates mother of director’s child to replace him on board

Wikipedia

entertainment

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stop Congress from blocking public access to science

Duchenne breakthrough therapy leaves behind pioneering families

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Trump demands the U.S. pay no more for drugs than other countries … again

CDC picks Alphabet's Verily for wasterwater surveillance contract

Medical leaders decry Supreme Court decision on affirmative action

Can medical device makers keep up in the race to treat obesity?

Dobbs anniversary: the lost opportunity of abortion as health care

WHO recommends second malaria vaccine

hotspot

Some top drug companies are starting to take action on climate

Medicare innovation center doesn’t save money, experts say

What we owe ALS patients — and why one company fell short

What will Novo Nordisk's VC do with its influx of cash?

Millions may soon lose Medicaid when they don't have to

Medicare innovation center doesn’t save money, experts say

focus

focus

explore

leisure time